Skip to main content
. 2020 Oct 12;3(4):867–878. doi: 10.20517/cdr.2020.53

Figure 3.

Figure 3

Structures of anti-tumor active 3,3’-diindolylmethane (DIM) derivatives (glycosides, tetraindole, and stabilized derivatives). Cell lines: A549 lung cancer, HeLa cervix cancer, MCF-7 breast cancer, PC3 prostate cancer, DU-145 prostate cancer, MiaPaCa-2 pancreas cancer, COLO-205 colon cancer, MDA-MB-231 breast cancer, SKOV-3 ovarian cancer, and HUVEC endothelial cells